NCT00038714已完成2 期
A Phase II Trial of SGN-00101 In The Treatment of Pediatric Recurrent Respiratory Papillomatosis
Nventa Biopharmaceuticals Corporation16 个研究点 分布在 1 个国家目标入组 27 人开始时间: 2001年11月1日最近更新:
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 27
- 试验地点
- 16
研究概览
简要总结
Recurrent Respiratory Papillomatosis (RRP) causes wart-like lesions along the throat area and can obstruct the airway or become malignant. The cause has been related to specific types of Human Papillomavirus (HPV). The purpose of the study is to assess the clinical effectiveness of a trial drug, SGN-00101, in children with RRP and also assess its safety.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 2 Years 至 18 Years（Child, Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Male or female between 2 and 18 yrs old, inclusive, who has documented RRP.
- •Patients with documented RRP
- •Subject is surgically debulked within 7 days before the first dose of SGN-
- •Subject has had at least 4 debulking surgeries for RRP, had no intersurgical intervals greater than 84 days during the period of the last 4 surgeries.
- •Subject is free of life threatening or serious concomitant disorders other than the disease under study.
- •Females of childbearing potential must have a negative pregnancy test and must be practicing an effective/appropriate method of birth control as determined by the Investigator.
排除标准
- •Subject has disease or status that causes compromise of the immune system.
- •Subject has a history of ionizing radiation therapy to the respiratory tract.
- •Patient has used concomitant medications that may suppress the immune system.
- •Subject has received any specific or non-specific immunotherapy intended as treatment for their RRP (i.e. mumps vaccine injected intralesionally) within 9 months prior to Week 0 of this study.
- •Subject has participated in a past study with SGN-00101
- •Pregnancy and lactation.
研究者
研究点 (16)
Loading locations...
相似试验
Unknown
不适用
Airway Intervention Registry (AIR): Recurrent Respiratory Papillomatosis (RRP)Recurrent Respiratory PapillomatosisHuman Papilloma VirusNCT03465280Newcastle-upon-Tyne Hospitals NHS Trust400
进行中（未招募）
1 期
Adjuvant PRGN-2012 in Adult Patients With Recurrent Respiratory PapillomatosisRecurrent Respiratory PapillomatosisPapillomavirus InfectionsPapillomaviridaeNCT04724980Precigen, Inc38
进行中（未招募）
2 期
Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)Respiratory Tract DiseasesNeoplasmsNeoplasms by Histologic TypeNeoplasms, Glandular and EpithelialNeoplasms, Squamous CellTumor Virus InfectionsInfectionsVirus DiseasesDNA Virus InfectionsPathologic ProcessesDisease AttributesRecurrenceRespiratory Tract InfectionsPapillomavirus InfectionsPapillomaNCT05797246National Cancer Institute (NCI)21
已完成
不适用
Recurrent Respiratory Papillomatosis and Extraesophageal RefluxRecurrent Respiratory PapillomatosisExtra Oesophageal RefluxLaryngeal CystNCT02592902University Hospital Ostrava60
终止
2 期
Celebrex (Celecoxib) Treatment of Laryngeal PapillomaLaryngeal PapillomaNCT00592319Boston University10